Universitätsklinik für Psychiatrie und Psychotherapeutische Medizin
Graz, 8010, Austria
NCT Number: NCT03275714
The primary objective of the clinical trial is to evaluate the data of an app for smartphones (BiP-App) with regard to sleep, movement, mood and communication behavior.
The data will be compared between two groups: people with a bipolar affective disorder and individuals without a psychiatric disorder.
Secondary objective of the trial is to investigate if it is possible to detect early warning symptoms of depressive / (hypo) manic episodes via the measured behavior patterns.
Furthermore it will be evaluated whether the BiP-app can find applicability in the examined patient group.
Study design: Clinical evaluation of a medical device without CE mark; Parallel study design
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Graz, 8010, Austria
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants use the BiP-App for 6 months. The app continuously records data on light and motion sensors, as well as Global Positioning System (GPS) and mood surveys.
Time frame: 6 months
in minutes
Time frame: 6 months
evaluated through motion sensors and localization services
Time frame: 6 months
evaluated by mood surveys
Time frame: 6 months
Frequency of usage of communication services
Time frame: 6 months
evaluated by a questionnaire
Medical University of Graz
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07129408
Agoraphobia, Alcohol Addiction
Bratislava, Slovakia
View Trial DetailsNCT05406414
Attention Deficit Disorder, Attention Deficit Disorder with Hyperactivity
Aarhus C, Denmark
View Trial DetailsNCT01722344
Bipolar Affective Disorder, Bipolar Disorder
Copenhagen, Denmark
View Trial DetailsNCT03925038
Anxiety Disorders, Bipolar Affective Disorder
Baltimore, Maryland, United States
View Trial Details